Skip to content
HowShorted

OCULAR THERAPEUTIX, INC short interest in 2020

In 2020, OCULAR THERAPEUTIX, INC's disclosed short interest ran from 13.84% of shares outstanding on 15 Jan 2020 to 8.17% on 31 Dec 2020, a change of -5.67 percentage points. The year's high was 13.84% on 15 Jan 2020 and its low 7.00% on 15 Dec 2020, averaging 10.54% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.15 days on 15 Jan 2020. Full history: OCULAR THERAPEUTIX, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for OCULAR THERAPEUTIX, INC in 2020

2020 in figures

Start of year
13.84% (15 Jan 2020)
End of year
8.17% (31 Dec 2020)
Change
-5.67 pp
High
13.84% (15 Jan 2020)
Low
7.00% (15 Dec 2020)
Average
10.54%
Highest days to cover
12.15 (15 Jan 2020)
SEC filings marked
13

Every report in 2020

OCULAR THERAPEUTIX, INC short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202013.84%12.15
31 Jan 202012.76%10.69
14 Feb 202011.77%10.67
28 Feb 202011.67%10.12
13 Mar 202011.09%2.46results (8-K), 10-K filed, results (8-K)
31 Mar 202011.22%5.61
15 Apr 202010.84%10.76results (8-K)
30 Apr 202011.59%8.43
15 May 202010.43%8.0610-Q filed, results (8-K)
29 May 202010.36%3.64
15 Jun 202010.69%7.80
30 Jun 202011.19%5.93
15 Jul 202011.24%8.58
31 Jul 202011.00%9.28results (8-K), results (8-K)
14 Aug 20208.96%11.4510-Q filed, results (8-K)
31 Aug 202010.39%7.58
15 Sep 202010.35%8.03
30 Sep 202011.01%10.53
15 Oct 202011.01%3.41results (8-K)
30 Oct 20209.77%6.45
13 Nov 20208.13%4.9410-Q filed, results (8-K)
30 Nov 20208.46%6.67
15 Dec 20207.00%4.13
31 Dec 20208.17%4.45

See also: OCULAR THERAPEUTIX, INC's full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.